A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 6, 1997, Pages 1914-1920

  Kerem, Eitan ^a   Rave Harel, Naama ^b   Augarten, Arie ^b   Madgar, Igal ^b   Nissim Rafinia, Malka ^b   Yahav, Yaacov ^b   Goshen, Ran ^b   Bentur, Lea ^b   Rivlin, Joseph ^b   Aviram, Micha ^b   Genem, Adnan ^b   Chiba Falek, Ornit ^b   Kraemer, Mordechai R ^b   Simon, Alexander ^b   Branski, David ^b   Kerem, Batsheva ^b  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHLORIDE TRANSPORT; CYSTIC FIBROSIS; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SWEAT;

EID: 8244257360     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.6.9196095     Document Type: Article

References (49)

1. Welsh, M. J., L.-C. Tsui, T. F. Boat, and A. L. Beaudet. 1995. Cystic fibrosis. In C. L. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. The Metabolic Basis of Inherited Disease, 7th ed. McGraw-Hill, New York. 3799-3876.
2. Anderson, M. P., D. P. Rich, R. J. Gregory, A. E. Smith, and M. J. Welsh. 1991. Generation of cAMP-activated chloride currents by expression of CFTR. Science 251:679-682.
3. Kartner, N., J. W. Hanrahan, T. J. Jensen, A. L. Naismith, S. Sun, C. A. Ackerley, E. F. Reyes, et al. 1991. Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance. Cell 64:681-691.
4. Bear, C. E., C. H. Li, N. Kartner, R. J. Bridges, T. J. Jensen, M. Ramjeesingh, and J. R. Riordan. 1992. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 68:809-818.
5. Rommens, J. M., M. C. Iannuzzi, B. Kerem, M. L. Drumm, G. Melmer, M. Dean, R. Rozmahel, J. L. Cole, D. Kennedy, N. Hidaka, M. Zsiga, M. Buchwald, J. R. Riordan, L.-C. Tsui, and F. S. Collins. 1989. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059-1065.
6. Riordan, J. R., J. M. Rommens, B. Kerem, N. Alon, R. Rozmahel, Z. Grzelcza, J. Zielenski, S. Lok, N. Plavsic, J.-L. Chou, M. L. Drumm, C. Iannuzzi, F. S. Collins, and L.-C. Tsui. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066-1073.
7. Kerem, B., J. M. Rommens, J. A. Buchanan, D. Markiewicz, T. K. Cox, A. Chakravarti, M. Buchwald, and L.-C. Tsui. 1989. Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073-1080.
8. Tsui, L. C. 1992. The spectrum of cystic fibrosis mutations. TIG 8:392-398.
9. Kerem, E., M. Corey, B. Kerem, J. M. Rommens, D. Markiewicz, H. Levison, L.-C. Tsui, and P. Durie. 1990. The relationship between genotype and phenotype in cystic fibrosis: analysis of the most common mutation (ΔF508). N. Engl. J. Med. 323:1517-1522.
10. Santis, G., L. Osborne, R. A. Knight, and M. E. Hodson. 1990. Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet 336:1081-1084.
11. Campbell, P. W., III, J. A. Phillips, III, M. R. Krishnamani, K. J. Maness, and T. A. Hajinski. 1991. Cystic fibrosis: relationship between clinical status and F508 deletion. J. Pediatr. 118:239-241.
12. Johansen, H. K., M. Nir, N. Hoiby, C. Koch, and M. Schwartz. 1991. Severity of cystic fibrosis in patients homozygous and heterozygous for AF508 mutation. Lancet 337:631-634.
13. Shoshani, T., A. Augarten, E. Gazit, N. Bashan, Y. Yahav, Y. Rivlin, A. Tal, H. Seret, L. Yaar, E. Kerem, and B. Kerem. 1992. Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease. Am. J. Hum. Genet. 50:222-228.
14. Kristidis, P., D. Bozon, M. Corey, D. Markiewicz, J. Rommens, L.-C. Tsui, and P. Durie. 1992. Genetic determinants of exocrine pancreatic function. Am. J. Hum. Genet. 50:1178-1184.
15. Osborn, L., G. Santis, M. Schwartz, K. Klinger, T. Dork, I. McIntosh, M. Schwartz, V. Nunes, M. Macek, Jr., J. Reiss, W. E. Highsmith, Jr., R. McMahon, G. Novelli, N. Malik, J. Burger, M. Anvret, A. Wallace, C. Williams, C. Mathew, R. Rozen, C. Graham, P. Gaparini, J. Bal, J. J. Cassiman, A. Balassopoulou, L. Davidow, S. Raskin, L. Kalaydijieva, B. Kerem, S. Richards, B. Simon-Bouy, M. Super, U. Wulbrand, M. Keston, X. Estivill, V. Vavrova, K. J. Friedman, D. Barton, B. Dallapiccola, M. Stuhrmann, F. Beards, A. J. M. Hill, P. F. Pignatti, H. Cuppens, D. Angelicheva, B. Tummler, D. J. H. Brock, T. Casals, M. Macek, Jr., J. Schmidtke, A. C. Magee, A. Bonizzato, C. DeBoeck, A. Kuffardjieva, M. Hodson, and R. A. Knight. 1992. Incidence and expression of the N1303K mutation of the cystic fibrosis (CFTR) gene. Hum. Genet. 89:653-658.
16. The cystic fibrosis genotype-phenotype consortium. 1993. Correlation between genotype and phenotype in patients with cystic fibrosis. N. Engl. J. Med. 329:1308-1313.
17. Highsmith, W. E., H. Lauraneli, M. S. Burch, Z. Zhou, J. C. Olsen, T. E. Boat, A. Spock, J. D. Gorvoy, L. Quittell, K. J. Friedman, L. M. Silverman, R. C. Boucher, and M. R. Knowles. 1994. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N. Engl. J. Med. 331:974-980.
18. Augarten, A., B. Kerem, Y. Yahav, S. Noiman, Y. Rivlin, A. Tal, H. Blau, L. Ben-Tur, A. Szeinberg, E. Kerem, and E. Gazit. 1993. Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10kb C→T mutation. Lancet 342:25-26.
19. Varon, R., M. Sturmann, M. Macek, A. Kufardjieva, D. Angelicheva, K. Magdorf, A. Jordanova, A. Savov, U. Wahn, and M. Macek. 1995. Pancreatic insufficiency and pulmonary disease in German and Slavic cystic fibrosis patients with the R347P mutation Hum. Mutat. 6:219-225.
20. Starfsfield, J. K., and J. M. Davis. 1975. Negative sweat tests and cystic fibrosis. Arch. Dis. Child. 50:463-466.
21. Stern, R. C., T. F. Boat, C. R. Abramowsky, L. W. Matthews, R. E. Wood, and C. F. Doershuk. 1978. Intermediate-range sweat chloride concentration and Pseudomonas bronchitis: a cystic fibrosis variant with preservation of exocrine pancreatic function. J.A.M.A. 239:2676-2680.
22. Davis, P. B., V. S. Hubbard, and P. A. Di Sant'agnese. 1980. Low sweat electrolytes in a patient with cystic fibrosis. Am. J. Med. 69:643-646.
23. Strong, T. V., L. S. Smit, S. V. Turpin, J. L. Cole, C. Tom Hon, T. L. Petty, M. W. Craig, E. C. Rosenaw, L.-C. Tsui, M. C. Iannuzzi, M. R. Knowles, and F. S. Collins. 1991. Cystic fibrosis gene mutation in two sisters with mild disease and normal sweat electrolyte levels. N. Engl. J. Med. 325:1630-1634.
24. Gan, K. H., H. J. Veeze, A. M. W. van den Ouweland, D. J. J. Halley, H. Scheffer, A. van der Hout, S. E. Overbeek, J. C. de Jongste, W. Bakker, and G. M. Heijerman. 1995. A cystic fibrosis mutation associated with mild lung disease. N. Engl. J. Med. 333:95-99.
25. Anguiano, A., R. D. Oates, J. A. Amos, M. Dean, B. Gerrard, C. Stewart, T. A. Maher, M. B. White, and A. Milunsky. 1992. Congenital bilateral absence of the vas deferens, a primary genital form of cystic fibrosis. J.A.M.A. 267:1794-1797.
26. Osborne, L. R., M. Lynch, P. G. Middleton, E. W. F. W. Alton, D. M. Geddes, J. R. Pryor, M. E. Hodson, and G. K. Santis. 1993. Nasal epithelial ion transport and genetic analysis of infertile men with congenital absence of the vas deferens. Hum. Mol. Genet. 2:1605-1609.
27. Culard, J. F., M. Desgeorges, P. Costa, M. Laussel, G. Razkatzara, H. Navratil, J. Demaille, and M. Claustres. 1994. Analysis of the whole CFTR coding regions and splice junctions in azoospermic men with congenital bilateral absence of epididymis or vas deferens. Hum. Genet. 93:467-470.
28. Oates, R. D., and J. A. Amos. 1994. The genetic basis of congenital absence of the vas deferens and cystic fibrosis. J. Androl. 15:1-8.
29. Osborne, L. R., E. W. F. W. Alton, and L.-C. Tsui. 1994. CFTR intron 9 poly-T tract length in men with congenital absence of the vas deferens. Pediatr. Pulmonol. 10(Suppl.):214.
30. Chillon, M., T. Casals, B. Mercier, L. Bassas, W. Lissens, S. Silber, M.-C. Romey, J. Ruiz-Romero, C. Verlingue, M. Claustres, V. Nunes, C. Ferec, and X. Estivill. 1995. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N. Engl. J. Med. 332:1475-1480.
31. Rave-Harel, N., I. Madgar, R. Goshen, M. Nissim-Rafina, A. Ziadni, A. Rahat, O. Chiba, Y. M. Kaiman, C. Brautbar, D. Levison, A. Augarten, E. Kerem, and B. Kerem. 1995. CFTR haplotype analysis reveals genetic heterogeneity in the etiology of congenital bilateral aplasia of the vas deferens. Am. J. Hum. Genet. 56:1359-1366.
32. Mercier, B., C. Verlingue, W. Lissens, S. J. Silber, G. Novelli, M. Bonduelle, M. P. Audrezet, and C. Ferec. 1995. Is congenital bilateral absence of vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients. Am. J. Hum. Genet 56:272-277.
33. Jarvi, K., J. Zielenski, M. Wilschanski, P. Durie, M. Buckspan, W. Tullis, D. Markievicz, and L.-C. Tsui. 1995. Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia. Lancet 345:1578.
34. Chu, C. H., B. C. Trapnell, S. M. Curristin, G. R. Cutting, and R. G. Crystal. 1992. Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of cystic fibrosis transmembrane conductance regulator gene is not associated with clinical manifestations of cystic fibrosis. J Clin. Invest. 90:785-790.
35. Chu, C. H., B. C. Trapnell, J. J. Murtagh, et al. 1991. Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator transcripts in normal bronchial epithelium. EMBO J. 10:1355-1363.
36. Chu, C. H., B. C. Trapnell, S. M. Curristin, G. R. Cutting, and R. G. Crystal. 1993. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat. Genet. 3:151-156.
37. Kerem, E., Y. M. Kalman, Y. Yahav, T. Shoshani, D. Abeliovich, A. Szeinberg, J. Rivlin, H. Blau, A. Tal, L. Ben-Tur, C. Springer, A. Augarten, S. Godfrey, I. Lerer, F. Branski, M. Freidman, and B. Kerem. 1995. Incidence of cystic fibrosis and distribution of mutations in the CFTR gene among the Jewish population of Israel. Hum. Genet. 96:193-197.
38. Winship, P. R. 1989. An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide. Nucleic Acids Res. 17: 1266-1269.
39. Zielenski, J., R. Rozmahel, D. Bozon, B. Kerem, Z. Grezelczak, J. R. Riordan, J. M. Rommens, and L.-C. Tsui. 1991. Genomic DNA sequences of the cystic fibrosis transmembrane conductance regulator. Genomics 10:214-228.
40. Polgar, G., and V. Promadhart. 1971. Pulmonary Function Testing in Children: Techniques and Standards. W.B. Saunders, Philadelphia.
41. Zielenski, J., P. Patrizio, M. Corey, D. Markiewicz, R. Ash, and L.-C. Tsui. 1995. Splice-variant in intron 8 as a partially penetrant mutation specific for congenital bilateral absence of the vas deferens. Pediatr. Pulmonol. 12(Suppl.):A89.
42. Kerem, E., J. Reisman, M. Corey, L. Ben-Tur, G. Canny, and H. Levison. 1992. Wheezing in infants with cystic fibrosis: clinical course, pulmonary function, and survival analysis. Pediatrics 90:703-706.
43. Warner, J. O., and B. W. Tailor. 1975. Association of cystic fibrosis and allergy. Arch. Dis. Child. 51:507-511.
44. Stewart, B., J. Zabner, A. P. Shuber, M. J. Welsh, and P. B. McCray. 1995. Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis. Am. J. Respir. Crit. Care Med. 151:899-903.
45. Knowles, M. R., J. Gatzy, and R. Boucher. 1981. Increased bioelectrical potential difference across respiratory epithelia in cystic fibrosis. N. Engl. J. Med. 305:1489-1495.
46. Knowles, M. R., A. M. Paradiso, and R. Boucher. 1995. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum. Gene. Ther. 6:445-455.
47. Culard, J. F., M. Desgeorges, P. Costa, M. Laussel, G. Razakatzara, H. Navratil, J. Demaille, and M. Claustres. 1994. Analysis of the whole CFTR coding regions and splice junctions in azoospermic mean with congenital bilateral aplasia of epididymis or vas deference. Hum. Genet. 93:467-470.
48. Dahlberg, J. E., and E. Lund. 1988. Structure and Function of Major and Minor Small Ribonucleoprotein Particles. Springer-Verlag, Berlin. 38-70.
49. Shoshani, T., E. Kerem, L. Ben-Tur, A. Tal, A. Szeinberg, Y. Yahav, A. Augarten, and B. Kerem. 1994. Association between the pulmonary function and levels of aberrantly spliced mRNA transcribed in epithelial cells from the 3849+ 10Kb C→T mutation. Pediatr. Pulmonol. 10:A213.